Drugs Containing Excipient (Inactive Ingredient) CARBOMER 934

Branded drugs containing CARBOMER 934 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Blenheim Pharmacal Inc	NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE	nitrofurantoin monohydrate/macrocrystalline	10544-086	CARBOMER 934
Rebel Distributors Corp	MUCINEX	guaifenesin	21695-870	CARBOMER 934
Rebel Distributors Corp	DIETHYLPROPION HCL CONTROLLED-RELEASE	diethylpropion hydrochloride	21695-876	CARBOMER 934

Generic drugs containing CARBOMER 934 excipient

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA, Inc.	etodolac	0093-1122	CARBOMER 934
Amneal Pharmaceuticals of New York LLC	lidocaine and prilocaine	0115-1468	CARBOMER 934
Walgreens	guaifenesin, dextromethorphan hbr	0363-0437	CARBOMER 934

Market Dynamics and Financial Trajectory for CARBOMER 934

Last updated: February 25, 2026

Overview
Carbomer 934 is a high molecular weight synthetic polymer used primarily as a thickening, gelling, and stabilizing agent in pharmaceutical formulations. It is a key excipient in topical, ophthalmic, and oral products, contributing to viscosity control and stability.

---

Market Overview and Demand Drivers

Global Market Size (2022-2027)
The pharmaceutical excipients market was valued at approximately USD 7.5 billion in 2022, with carbomers representing about 10-15% of the segment. The demand for Carbomer 934 is driven by the growth in topical and ophthalmic drug formulations.

Key Demand Sectors:

• Dermatological drugs: Eczema, psoriasis, and anti-aging products rely on Carbomer 934 for gel formulation.
• Ophthalmic products: Eyes drops and gels require carbomers for viscosity.
• Oral care: Toothpaste and oral gels utilize Carbomer 934 for texture.

Regional Market Distribution (2022):

Region	Market Share	Growth Rate (2022-2027)
North America	40%	4.8%
Europe	25%	3.9%
Asia-Pacific	25%	6.3%
Latin America & MEA	10%	4.2%

Growth in Asia-Pacific surpasses other regions due to expanding pharmaceutical manufacturing and increasing regulatory approvals.

---

Competitive Landscape

• Major Suppliers:

  • Ashland Global Holdings Inc. uses proprietary manufacturing processes, with estimated 45% market share.
  • Lubrizol Corporation holds approximately 20%, offering high-purity grades.
  • Sihe Pharmaceutical and other regional producers fill the remainder.

• Key Factors Influencing Competition:

  • Price: Raw material costs affect pricing strategies.
  • Purity & Quality: High-purity carbomers command premium pricing, crucial for ophthalmic applications.
  • Regulatory Approvals: Suppliers with formal FDA, EMA, and other certifications gain easier market access.

---

Production Market and Supply Chain Factors

• Raw Material Supply: The primary raw material is acrylic acid, which is derived from propylene. Fluctuations in propylene prices impact Carbomer 934 costs.
• Manufacturing Complexity: Requires controlled polymerization processes to ensure consistent molecular weight and viscosity.
• Supply Chain Dynamics: Pandemic-related disruptions caused temporary shortages, resulting in price spikes in 2020-2021.

---

Financial Trajectory and Pricing Trends

Pricing Dynamics (2022-2027)

Year	Average Price per kg (USD)	Variations	Notes
2022	55-65	Stable	Market normalization post-pandemic
2023	58-68	Slight increase	Raw material costs impact pricing
2024-2025	60-70	Mild upward trend	Regulatory standards tighten
2026-2027	62-75	Projected increase	Supply constraints persist

Revenue Projections

• Forecasted Market Revenue Growth: Compound annual growth rate (CAGR) projected at 4.5% from 2022 to 2027, reaching USD 1.2 billion.
• Major Revenue Contributors: North America and Asia-Pacific remain dominant, with increasing contribution from emerging markets.

---

Regulatory and R&D Factors

• Regulatory Standards: Carbomer 934 complies with USP, EP, and JP standards. Increasing regulatory oversight in emerging markets may influence formulations and supply.
• Innovation Trends: Development of low-viscosity versions and alternative polymers for niche applications.

---

Risks and Opportunities

Risks:

• Raw material volatility affecting production costs.
• Regulatory hurdles restricting market access.
• Oversupply in mature markets leading to price pressures.

Opportunities:

• Expansion in Asia-Pacific through local manufacturing partnerships.
• Emerging applications in controlled-release formulations.
• Development of eco-friendly and biodegradable variants.

---

Key Takeaways

• Carbomer 934's market is expanding at around 4.5% annually, driven by growth in topical and ophthalmic formulations.
• Asia-Pacific leads demand growth, supported by manufacturing expansion.
• Pricing is influenced by raw material costs, regulatory changes, and supply chain stability.
• Major suppliers are consolidating market share through quality, certifications, and strategic investments.
• Innovation and regulatory compliance are critical for sustaining growth, especially in emerging regions.

---

FAQs

1. What factors influence Carbomer 934 prices in the pharmaceutical market?
Prices are affected by raw material costs (primarily acrylic acid), regulatory compliance costs, supply chain stability, and competitive pricing strategies.

2. How does regional demand vary for Carbomer 934?
North America and Europe have mature markets with steady demand, while Asia-Pacific exhibits higher growth rates due to expanding pharmaceutical manufacturing and regulatory approval processes.

3. What regulatory standards apply to Carbomer 934 in pharmaceuticals?
It complies with USP, European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP) standards. Certification simplifies market entry, especially for ophthalmic and topical products.

4. Which companies dominate the Carbomer 934 supply market?
Ashland Global Holdings Inc. and Lubrizol Corporation hold approximately 65% combined market share, with regional players filling the rest.

5. What future applications could impact the demand for Carbomer 934?
Innovations in controlled-release formulations, biodegradable gel products, and personalized medicine could expand demand and open new market segments.

---

References

1. MarketsandMarkets. (2022). Pharmaceutical Excipients Market by Type, Application, and Region – Global Forecast to 2027.
2. Arcadia Group. (2022). Raw Material Price Trends in Polymer Production.
3. United States Pharmacopeia. (2021). Carbomer Monograph.
4. European Medicines Agency. (2022). Excipient Regulations in Pharmaceuticals.
5. Company Annual Reports (2022-2023). Ashland Global Holdings Inc. and Lubrizol Corporation.